|
Volumn 275, Issue 36, 2000, Pages 28173-28179
|
Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase: Mediation through different signaling pathways
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (2 AMINO 3 METHOXYPHENYL)CHROMONE;
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
CYCLOOXYGENASE 2;
FLUFENAMIC ACID;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LIPOPOLYSACCHARIDE;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
SULINDAC SULFIDE;
TROGLITAZONE;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL CELL;
ARTICLE;
CANCER CELL;
CANCER PREVENTION;
COLON CANCER;
COLON CARCINOGENESIS;
CONTROLLED STUDY;
DRUG EFFECT;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
MACROPHAGE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROSTAGLANDIN SYNTHESIS INHIBITION;
ADENOCARCINOMA;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
COLONIC NEOPLASMS;
CYCLOOXYGENASE 2;
ENZYME INDUCTION;
FLUFENAMIC ACID;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
HUMANS;
ISOENZYMES;
LIPOPOLYSACCHARIDES;
MACROPHAGES;
MEMBRANE PROTEINS;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE II;
PROSTAGLANDIN D2;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
SULINDAC;
TRANSCRIPTION FACTORS;
TUMOR CELLS, CULTURED;
TUMOR NECROSIS FACTOR-ALPHA;
ANIMALIA;
|
EID: 0034623141
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M002329200 Document Type: Article |
Times cited : (110)
|
References (43)
|